CD274 and non-small cell lung carcinoma: On the one hand, clinicians must understand the guiding significance of the PD-L1 test in the treatment of NSCLC, be familiar with the difference between concomitant and complementary diagnosis and be able to skillfully interpret PD-L1 test reports.